Michael (Mike) Halaiko, CIPP/E, a shareholder in Baker Donelson’s Baltimore and Washington, D.C. offices, leads the firm’s Life Sciences and Health Technology Group. Mike advises pharmaceutical, biotechnology, clinical research, and health technology organizations on the regulatory, privacy, contracting, and operational risk. His work includes global data privacy, AI governance, clinical research compliance, vendor and research agreements, and the practical challenges of collaborating across sponsors, CROs, SMOs, and technology providers.